Literature DB >> 21605816

Diagnosis and clinical features of epidermolysis bullosa acquisita.

Frédéric Caux1.   

Abstract

Epidermolysis bullosa acquisita (EBA) is a rare autoimmune subepidermal blistering disease characterized by immune deposits on anchoring fibrils of cutaneous and mucosal basement membrane zones. It is due to circulating antibodies directed to type VII collagen. Clinical manifestations include a classical form with skin fragility, blisters and scars on trauma-prone surfaces, an inflammatory form, and a cicatricial pemphigoid-like form. Specialized tests available in only certain laboratories are necessary to confirm a diagnosis of EBA, such as immunoelectron microscopy, immunoblotting, or ELISA using recombinant proteins. A frequent association between EBA and Crohn disease has been observed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605816     DOI: 10.1016/j.det.2011.03.017

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

1.  Epidermolysis bullosa acquisita.

Authors:  Denise Miyamoto; Juliana Olivieri Gordilho; Claudia Giuli Santi; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2022-06-11       Impact factor: 2.113

2.  Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up.

Authors:  Naveed Sami
Journal:  JAAD Case Rep       Date:  2015-08-25

3.  Advanced Diagnostic Techniques in Autoimmune Bullous Diseases.

Authors:  Anuradha Jindal; Raghavendra Rao; Balbir S Bhogal
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

Review 4.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

5.  Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.

Authors:  Hiroaki Iwata; Artem Vorobyev; Hiroshi Koga; Andreas Recke; Detlef Zillikens; Catherine Prost-Squarcioni; Norito Ishii; Takashi Hashimoto; Ralf J Ludwig
Journal:  Orphanet J Rare Dis       Date:  2018-09-04       Impact factor: 4.123

Review 6.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.